Top Tips for Patenting Antibodies in Europe

Rebecca Tollervey

Rebecca Tollervey
11 Nov 2019

Antibody development is a mature field of technology.  There are relatively few new targets, and the engineering of antibodies is becoming ever more.

T cell engagers - dark horses of immunotherapy

Adam Gregory

Adam Gregory
26 Sep 2019

Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in recent years, but the potential of T cell Engager.

Obtaining patent protection for fermentation processes and products – the European perspective

Tanis Keirstead

Tanis Keirstead
19 Sep 2019

Fermented foods have been known for millennia and form an important part of many national cuisines. Initially used primarily to preserve foods and.

Food of the future – regulating and protecting gene-edited crops

Simon Kremer

Simon Kremer
11 Sep 2019

A recent episode of the BBC World Service’s excellent series “50 Things that made the modern economy” (now up to ‘thing’ 75) concerned plant breeding.

DIY biology dilemma – regulating biohacking

Camille Terfve

Camille Terfve
04 Sep 2019

Science kits may have inspired generations of children to become scientists, and those grown up children might be surprised that there may be cause for.

Shifting treatments: cancer as a manageable disease

Nick Sutcliffe

Nick Sutcliffe
29 Aug 2019

As new treatments drive a shift towards treating cancer as a manageable disease we are seeing greater collaboration across the life sciences sector.  

Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance

Camille Terfve

Camille Terfve
15 Aug 2019

In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting thoughts about ways to obtain US patents in the field of.

Challenges Post­ Selex

Richard Clegg

Richard Clegg
13 Aug 2019

Twenty­-five years ago Tuerk and Gold reported the Selex method. Being the first European patent attorney to prosecute patents relating to.

Speeding things up at the EPO

Eleanor Maciver

Eleanor Maciver
07 Aug 2019

There are many reasons why an applicant may wish to speed up the prosecution of an application. For example, an applicant may want a patent granted.

EPO Quality Report 2018

Tom Furnival

Tom Furnival
12 Jul 2019

July has seen the publishing of the European Patent Office’s (EPO) 2018 Quality Report.  This is the first to be released under the direction of the.

New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents?

Emily Hayes

Emily Hayes
09 Jul 2019

Revised Rules of Procedure at the Boards of Appeal have been approved by The Administrative Council of the EPO. The Rules will come into force on 1.

A Myriad of effects

Emily Hayes

Emily Hayes
05 Jul 2019

Even though the decision in Myriad is now 6 years old and there have been several follow-on cases, the general principles still hold true. Here, Emily.

Medicinal cannabis: recent changes and future innovations

Callum McGuinn

Callum McGuinn
18 Jun 2019

Government policy on the prescription of cannabis-derived medicines has undergone some interesting and important changes over the past few months, both.

EU approves first gene therapy for patients with a mild form of β-Thalassemia

Frances Salisbury

Frances Salisbury
04 Jun 2019

Exciting news in the personalised medicine space – the EU has just approved the first gene therapy for patients with a mild form of β-Thalassemia. .

Precision therapeutics for the precision medicine era

Adam Gregory

Adam Gregory
17 May 2019

In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.

Personalised medicine: patient stratification

Simon Kiddle

Simon Kiddle
29 Apr 2019

While the general idea of customising treatment to patients is not new, the degree to which treatments may be tailored to patient subgroups defined by.

Pioneers of precision medicine

Frances Salisbury

Frances Salisbury
15 Apr 2019

Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical decisions. But who has paved the way and who is.

Hydrogen: the storage question

Matthew Smith

Matthew Smith
04 Apr 2019

There’s a lot to like about hydrogen.  It’s light; it’s abundant (at least atomically - water and hydrocarbons contain plenty of hydrogen atoms); it’s.

The road to autonomous

Christoph Moeller

Christoph Moeller
28 Mar 2019

In a recent article published in Intellectual Property Magazine, Christoph Moeller explores the data issues surrounding future mobility. 

Dosage regimen patents: bruised but not beaten

Julie Carlisle

Julie Carlisle
28 Mar 2019

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.